-transparent.png){kind=logo}
The management, complications and outcome of two small children who developed Candida albicans peritonitis are reported. Both children developed peritonitis while on continuous ambulatory peritoneal dialysis (CAPD) but their fungal infections were treated differently. In one patient, Amphotericin B (1-4 micrograms/ml) was added to the dialysate; infection resolved but an extensive fibrous reaction developed in the peritoneal cavity making subsequent CAPD ineffective. The second patient was treated with a recently introduced oral antifungal agent, Ketoconazole; her catheter was removed. This patient recovered without any identifiable side effects of the drug. This report discusses the clinical course of two different approaches to Candida peritonitis and suggests certain recommendations regarding the treatment of this uncommon, but potentially lethal complication of CAPD.
R J Hogg, and
B S Arant, and
M T Houser
October 1983,
Medicina clinica,
R J Hogg, and
B S Arant, and
M T Houser
May 1988,
The Journal of infection,
R J Hogg, and
B S Arant, and
M T Houser
August 1989,
Scottish medical journal,
R J Hogg, and
B S Arant, and
M T Houser
January 1988,
Mycoses,
R J Hogg, and
B S Arant, and
M T Houser
January 1985,
American journal of diseases of children (1960),
R J Hogg, and
B S Arant, and
M T Houser
May 1983,
Pediatrics,
R J Hogg, and
B S Arant, and
M T Houser
May 1986,
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
R J Hogg, and
B S Arant, and
M T Houser
January 1983,
Pediatric infectious disease,
R J Hogg, and
B S Arant, and
M T Houser
April 1986,
Scottish medical journal,
R J Hogg, and
B S Arant, and
M T Houser
June 1982,
The Journal of antimicrobial chemotherapy,
